SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-19-015647
Filing Date
2019-03-18
Accepted
2019-03-18 17:05:33
Documents
4
Period of Report
2019-04-19

Document Format Files

Seq Description Document Type Size
1 PRE 14A a19-6642_1pre14a.htm PRE 14A 533213
2 GRAPHIC g66421bgi001.jpg GRAPHIC 6095
3 GRAPHIC g66421bci001.jpg GRAPHIC 4938
4 GRAPHIC g66421bci002.jpg GRAPHIC 3128
  Complete submission text file 0001104659-19-015647.txt   554183
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36856 | Film No.: 19689061
SIC: 2834 Pharmaceutical Preparations